• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    88 Biggest Movers From Yesterday

    5/27/22 3:41:18 AM ET
    $AFRM
    $AKA
    $AMRS
    $APCX
    Finance: Consumer Services
    Finance
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AFRM alert in real time by email

    Gainers

    • Creatd, Inc. (NASDAQ:CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
    • Apyx Medical Corporation (NASDAQ:APYX) rose 51.9% to settle at $5.62 after the company received the FDA 510(k) clearance for use of renuvion cosmetic technology in dermal resurfacing procedures.
    • Planet Green Holdings Corp. (NYSE:PLAG) gained 51.2% to close at $0.70. Planet Green recently reported a $4 million offering.
    • SciSparc Ltd. (NASDAQ:SPRC) shares surged 41.1% to close at $3.33. SciSparc reported Ethics Committee approval to conduct a Phase IIb trial in Tourette Syndrome.
    • Guardion Health Sciences, Inc. (NASDAQ:GHSI) climbed 37.5% to close at $0.2040. Guardion Health Sciences said its new Viactiv Omega Boost Gel Bites is now available for purchase on Amazon.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares jumped 37% to close at $0.87 after dipping 18% on Wednesday.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) shares climbed 31.8% to close at $0.8829 on Thursday. Healthcare Triangle recently posted a Q1 loss of $0.06 per share.
    • EBET, Inc. (NASDAQ:EBET) gained 31.3% to settle at $3.44.
    • VIQ Solutions Inc. (NASDAQ:VQS) surged 29.6% to close at $1.49.
    • OpGen, Inc. (NASDAQ:OPGN) gained 27.2% to settle at $0.4802 as the company reported publication of results from major clinical study using unyvero hospitalized pneumonia panel in The Lancet Respiratory Medicine.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) rose 25.7% to close at $8.11. Alpha Tau Medical reported R&D expenses for quarter ended march 31, 2022 of $5.2 million.
    • Quotient Limited (NASDAQ:QTNT) gained 25.6% to settle at $0.3536.
    • Baozun Inc. (NASDAQ:BZUN) climbed 25.5% to close at $9.90 after the company reported better-than-expected Q1 sales results.
    • Talkspace, Inc. (NASDAQ:TALK) gained 25.5% to settle at $1.33.
    • MOGU Inc. (NYSE:MOGU) gained 25% to close at $2.20.
    • Modine Manufacturing Company (NYSE:MOD) shares climbed 24.7% to settle at $10.85 as the company reported fourth-quarter FY22 sales growth of 12% year-on-year, to $574.4 million, beating the consensus of $538.02 million.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) jumped 24% to close at $2.07. GeoVax Labs recently announced a registered direct offering and a private placement at $1.65 per share and issued unregistered preferred investment options for a combined total of roughly $20 million.
    • Aspira Women's Health Inc. (NASDAQ:AWH) gained 23.1% to close at $0.5175. Aspira Womens Health recently posted a Q1 loss of $0.08 per share.
    • Integra Resources Corp. (NYSE:ITRG) climbed 22.3% to close at $1.15.
    • Zhihu Inc. (NYSE:ZH) rose 22.1% to close at $1.66. Zhihu reported first-quarter FY22 revenue growth of 55.4% year-on-year to $117.2 million, beating the consensus of $107.3 million.
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) gained 22% to close at $0.8050.
    • Dollar Tree, Inc. (NASDAQ:DLTR) jumped 21.9% to close at $162.80 after the company reported better-than-expected Q1 results and raised FY22 guidance.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) jumped 21.7% to settle at $28.02.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) rose 21.6% to close at $0.8528.
    • Petros Pharmaceuticals recently posted a Q1 loss of $0.01 per share.
    • Eargo, Inc. (NASDAQ:EAR) gained 20.8% to close at $1.28.
    • Charah Solutions, Inc. (NYSE:CHRA) climbed 20.8% to settle at $3.14.
    • Standard BioTools Inc. (NASDAQ:LAB) rose 20.2% to close at $2.02.
    • Enochian Biosciences, Inc. (NASDAQ:ENOB) jumped 20% to settle at $4.44. Hindenburg Research recently tweeted Enochian's founder and inventor of its scientific breakthroughs has been arrested in a murder for hire plot in California.
    • Insignia Systems, Inc. (NASDAQ:ISIG) gained 19.4% to close at $9.43.
    • Macy's, Inc. (NYSE:M) climbed 19.3% to settle at $22.92 after the company reported better-than-expected Q1 EPS and sales results and raised FY22 EPS guidance above estimates.
    • Second Sight Medical Products, Inc. (NASDAQ:EYES) gained 19.1% to close at $2.12. Second Sight Medical Products Director Gregg Williams acquired a total of 222,598 shares at an average price of $1.97.
    • RumbleON, Inc. (NASDAQ:RMBL) jumped 19% to close at $16.09.
    • Endo International plc (NASDAQ:ENDP) gained 18.5% to close at $0.4709. Endo International recently initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported.
    • QualTek Services Inc (NASDAQ:QTEK) rose 18.3% to close at $1.68.
    • EZFill Holdings Inc. (NASDAQ:EZFL) gained 18.3% to settle at $0.43.
    • Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) jumped 17.4% to settle at $3.65. Eledon Pharmaceuticals recently posted a Q1 loss of $0.69 per share.
    • Global Internet of People, Inc. (NASDAQ:SDH) rose 17.3% to close at $1.97.
    • Zentek Ltd. (NASDAQ:ZTEK) jumped 16.9% to settle at $2.14. The stock began trading on the Nasdaq on Tuesday following an uplisting from the OTC Pink Sheets.
    • BioLineRx Ltd. (NASDAQ:BLRX) rose 16.9% to close at $1.45.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) gained 16.7% to close at $4.13.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) rose 16.3% to settle at $8.00.
    • Dutch Bros Inc. (NYSE:BROS) gained 16% to close at $35.72.
    • DXC Technology Company (NYSE:DXC) surged 16% to settle at $34.16 despite worse-than-expected Q4 results. The company also announced a contract extension for the London insurance market.
    • Profound Medical Corp. (NASDAQ:PROF) gained 15.9% to close at $9.02.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) rose 15.8% to settle at $1.3662. Helius Medical Tech recently posted a Q1 loss of $1.15 per share.
    • Genius Group Limited (NYSE:GNS) gained 15.7% to close at $7.80. Genius Group recently acquired E-Squared Education Enterprises, a South Africa-based school and vocational college.
    • VNET Group, Inc. (NASDAQ:VNET) climbed 14.9% to close at $5.40. VNET recently reported Q1 earnings results.
    • Alibaba Group Holding Limited (NYSE:BABA) rose 14.8% to settle at $94.48 after the company reported better-than-expected Q4 EPS and sales results.
    • Build-A-Bear Workshop, Inc. (NYSE:BBW) rose 14.6% to close at $19.12 after the company reported better-than-expected Q1 EPS and sales results.
    • Movado Group, Inc. (NYSE:MOV) gained 14.3% to close at $36.61 after the company reported better-than-expected Q1 results and issued FY23 guidance above estimates.
    • Dollar General Corporation (NYSE:DG) jumped 13.7% to close at $222.13 after the company reported better-than-expected Q1 EPS and sales results and reiterated FY22 EPS guidance.
    • Williams-Sonoma, Inc. (NYSE:WSM) rose 13.1% to close at $130.00 as the company reported first-quarter revenue growth of 8.1% year-over-year to $1.89 billion, beating the consensus of $1.81 billion.
    • Tupperware Brands Corporation (NYSE:TUP) jumped 12.8% to close at $6.86.
    • Vivid Seats Inc. (NASDAQ:SEAT) rose 12.6% to close at $8.88 after the company announced a $40 million share repurchase program.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) rose 12.5% to close at $0.3601. Roth Capital maintained First Wave BioPharma with a Buy and lowered the price target from $20 to $9.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) rose 12.5% to close at $2.97. Immix Biopharma recently announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
    • Trevena, Inc. (NASDAQ:TRVN) rose 12.2% to settle at $0.2475.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 11.5% to close at $7.55.
    • Groupon, Inc. (NASDAQ:GRPN) gained 10.9% to close at $15.49. Groupon’s 10% owner Pale Fire Capital Se acquired a total of 458,794 shares at an average price of $11.55.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) gained 10.7% to close at $1.0022. Benitec Biopharma posted a Q3 loss of $0.40 per share.
    • Liquidia Corporation (NASDAQ:LQDA) shares gained 10.4% to close at $4.03. Liquidia Technologies recently posted a Q1 loss of $0.30 per share.
    • iQIYI, Inc. (NASDAQ:IQ) rose 9.2% to settle at $3.91 after reporting upbeat Q1 earnings.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) gained 8.4% to close at $0.5203.
    • Signet Jewelers Limited (NYSE:SIG) rose 8.1% to close at $60.99.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) gained 7.6% to close at $0.3175 after jumping 118% on Wednesday. Very Good Food Company increased retail distribution across Canada with Loblaw Companies Ltd.
    • Amyris, Inc. (NASDAQ:AMRS) rose 7.1% to close at $2.27. Piper Sandler recently initiated coverage on Amyris with a Neutral rating and announced a price target of $2.5.

     

    Losers

    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) shares fell 68.3% to settle at $1.07 on Thursday after announcing new FDA request for experimental narcolepsy drug.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares dipped 58.2% to close at $0.5770 on Thursday as the company reported Data Safety Monitoring Board update on U.S. National Institutes of Health (NIH) study of ZYESAMI® (aviptadil) in critical COVID-19.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) dropped 36.6% to close at $3.39.
    • MSP Recovery, Inc. (NASDAQ:MSPR) fell 31.1% to close at $2.57. MSP Recovery reaffirmed its sales guidance.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) declined 27.8% to close at $1.1050.
    • Bright Green Corporation (NYSE:BGXX) fell 24.8% to close at $7.89.
    • Nutanix, Inc. (NASDAQ:NTNX) declined 23% to close at $16.50 after the company issued Q4 and FY22 sales guidance below estimates.
    • Nurix Therapeutics, Inc. (NASDAQ:NRIX) fell 22.7% to settle at $7.88 as the company reported positive dose finding data in chronic lymphocytic leukemia and advanced NX-2127 to next phase of clinical development.
    • Catalyst Biosciences, Inc. (NASDAQ:CBIO) dipped 22.4% to close at $1.11. Catalyst Biosciences recently announced it sold its complement portfolio for $60 million.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) dipped 19.8% to close at $0.1471 after the company announced a 1-for-10 reverse stock split.
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) shares fell 19.5% to close at $0.0741 after jumping 51% on Wednesday. Genocea Biosciences recently said it is winding down operations and delisting from NASDAQ.
    • Happiness Development Group Limited (NASDAQ:HAPP) shares fell 18% to close at $0.1951. Happiness Development Group shares jumped around 32% on Wednesday after the company reported a deal to sell up to 2000 electric vehicles, potentially valued at roughly $30 million.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) tumbled 17.3% to close at $0.43.
    • BIMI International Medical Inc. (NASDAQ:BIMI) fell 16.8% to close at $0.4260.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 16% to close at $2.37. Vinco Ventures’ board of directors announced the delay of the distribution date for the previously announced spin-off of Cryptyde, Inc. due to contractual and regulatory conditions.
    • AppTech Payments Corp. (NASDAQ:APCX) fell 13.9% to close at $0.9990.
    • 36Kr Holdings Inc. (NASDAQ:KRKR) declined 13.5% to settle at $0.90.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) fell 12.9% to close at $3.70.
    • Viasat, Inc. (NASDAQ:VSAT) fell 11.1% to close at $36.55 following downbeat quarterly sales.
    • Q&K International Group Limited (NASDAQ:QK) dipped 8.1% to close at $0.9378.
    • The Kraft Heinz Company (NASDAQ:KHC) fell 6.1% to close at $37.07 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $40 to $34.
    • Snowflake Inc. (NYSE:SNOW) fell 4.5% to close at $126.80 after the company reported financial results and issued guidance below analyst estimates.
    Get the next $AFRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFRM
    $AKA
    $AMRS
    $APCX

    CompanyDatePrice TargetRatingAnalyst
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    Crescent Biopharma Inc.
    $CBIO
    1/28/2026$35.00Overweight
    Piper Sandler
    Affirm Holdings Inc.
    $AFRM
    1/27/2026$100.00Hold → Buy
    Needham
    Dutch Bros Inc.
    $BROS
    1/26/2026$82.00Buy
    Citigroup
    Crescent Biopharma Inc.
    $CBIO
    1/21/2026$35.00Buy
    Guggenheim
    The Kraft Heinz Company
    $KHC
    1/21/2026$22.00Neutral → Underperform
    BNP Paribas Exane
    Dollar Tree Inc.
    $DLTR
    1/21/2026Neutral → Underperform
    BNP Paribas Exane
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    More analyst ratings

    $AFRM
    $AKA
    $AMRS
    $APCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

    PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced that it will effect a 1-for-60 reverse stock split of its common stock. The reverse stock split will become effective at 12:01 a.m. Eastern Time on Tuesday, February 10, 2026, and the Company's common stock will commence trading on the Nasdaq Capital Market on a post-split basis at the opening of the market on February 10, 2026, pending confirmation by the Depository Trust Company and the Nasdaq. The Company

    2/6/26 10:19:00 AM ET
    $HCTI
    EDP Services
    Technology

    Affirm and Virgin Media O2 partner to bring flexible financing to O2 customers

    Affirm and Virgin Media O2 are today announcing a new partnership that will see the transparent and flexible payment network provide upfront and honest hardware financing to O2 - one of the UK's leading mobile providers. Through the partnership, new and existing O2 customers will be able to enjoy increased flexibility to choose a payment option that suits their needs when purchasing a device. Affirm will provide financing options for mobile phones and other hardware, including headphones and games consoles, offering a wide choice of monthly payment plans. Customers who take out one of these payment plans will never be charged late or hidden fees when paying off their loan, and unlike pa

    2/6/26 3:00:00 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Affirm reports second fiscal quarter 2026 results

    Affirm Holdings, Inc. (NASDAQ:AFRM) ("Affirm" or the "Company") today reported financial results for its fiscal 2026 second quarter ended December 31, 2025. The results, which include a shareholder letter furnished to the U.S. Securities and Exchange Commission on Form 8-K, can be found in the "Quarterly Results" section of the Company's investor relations website at https://investors.affirm.com/. Affirm will host a conference call and webcast to discuss its financial results today at 2:00pm PT. Hosting the call will be Max Levchin, Founder and Chief Executive Officer, Michael Linford, Chief Operating Officer, and Rob O'Hare, Chief Financial Officer. The conference call will be webcast li

    2/5/26 4:30:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFRM
    $AKA
    $AMRS
    $APCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Speiser Michael L sold $8,383,608 worth of shares (50,741 units at $165.22), decreasing direct ownership by 2% to 23,718 units (SEC Form 4)

    4 - Snowflake Inc. (0001640147) (Issuer)

    2/6/26 7:34:20 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    Director Mccamish Mark Anthony gifted 67,025 units of Ordinary Shares and received a gift of 67,025 units of Ordinary Shares (SEC Form 4)

    4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)

    2/6/26 4:10:10 PM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer, Secretary Reilly John Charles was granted 20,542 shares, increasing direct ownership by 2% to 1,038,685 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/4/26 8:34:35 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    SEC Filings

    View All

    SEC Form 10-Q filed by ViaSat Inc.

    10-Q - VIASAT INC (0000797721) (Filer)

    2/6/26 5:20:17 PM ET
    $VSAT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Healthcare Triangle Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Healthcare Triangle, Inc. (0001839285) (Filer)

    2/6/26 4:01:40 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form 144 filed by Snowflake Inc.

    144 - Snowflake Inc. (0001640147) (Subject)

    2/6/26 1:39:17 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $AFRM
    $AKA
    $AMRS
    $APCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fernandez Raul J bought $250,706 worth of shares (16,446 units at $15.24), increasing direct ownership by 2% to 816,001 units (SEC Form 4)

    4 - DXC Technology Co (0001688568) (Issuer)

    2/3/26 5:55:04 PM ET
    $DXC
    EDP Services
    Technology

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:05:34 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Affirm upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Affirm from Equal-Weight to Overweight and set a new price target of $76.00

    2/3/26 6:49:01 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Piper Sandler initiated coverage on Crescent Biopharma with a new price target

    Piper Sandler initiated coverage of Crescent Biopharma with a rating of Overweight and set a new price target of $35.00

    1/28/26 7:10:21 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Affirm upgraded by Needham with a new price target

    Needham upgraded Affirm from Hold to Buy and set a new price target of $100.00

    1/27/26 8:33:32 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFRM
    $AKA
    $AMRS
    $APCX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    Financials

    Live finance-specific insights

    View All

    Affirm reports second fiscal quarter 2026 results

    Affirm Holdings, Inc. (NASDAQ:AFRM) ("Affirm" or the "Company") today reported financial results for its fiscal 2026 second quarter ended December 31, 2025. The results, which include a shareholder letter furnished to the U.S. Securities and Exchange Commission on Form 8-K, can be found in the "Quarterly Results" section of the Company's investor relations website at https://investors.affirm.com/. Affirm will host a conference call and webcast to discuss its financial results today at 2:00pm PT. Hosting the call will be Max Levchin, Founder and Chief Executive Officer, Michael Linford, Chief Operating Officer, and Rob O'Hare, Chief Financial Officer. The conference call will be webcast li

    2/5/26 4:30:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Viasat Releases Third Quarter Fiscal Year 2026 Financial Results

    CARLSBAD, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ:VSAT), a global leader in satellite communications, today published its third quarter fiscal year 2026 financial results. The letter to shareholders and accompanying webcast slides are available on the Investor Relations section of the company's website. Conference Call DetailsAs previously announced, Management will host a conference call to discuss the results today, Thursday, February 5, 2026 at 2:30 p.m. PT (5:30 p.m. ET). Access Information: Dial-in: (800) 715-9871 (U.S./Canada toll-free) or (646) 307-1963 (international)Conference ID: 3835630Live webcast: Available on Viasat's Investor Relations website. A r

    2/5/26 4:05:00 PM ET
    $VSAT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Nutanix Announces Date and Conference Call Information for Second Quarter Fiscal Year 2026 Financial Results

    SAN JOSE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ:NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second quarter of fiscal year 2026, which ended January 31, 2026, after U.S. markets close on Wednesday, February 25, 2026. Nutanix will host a conference call and earnings webcast beginning at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day to discuss the company's financial results. Interested parties may access the conference call by registering at this link to receive dial in details and a unique PIN number. The conference call will also be webcast live on the Nutanix Investor Relatio

    2/5/26 4:05:00 PM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    $AFRM
    $AKA
    $AMRS
    $APCX
    Leadership Updates

    Live Leadership Updates

    View All

    Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor

    DOYLESTOWN, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that exploit cancer-specific vulnerabilities while minimizing damage to healthy cells, today announced the appointment of Eugene (Gene) Kennedy, MD, as Chief Medical Advisor. Dr. Kennedy joins Aprea at an important time, following the Company's recent early clinical proof-of-concept demonstrated in its ongoing Phase 1 dose-escalation study evaluating the WEE1 inhibitor APR-1051 in patients with advanced solid tumors. He is a highly accomplished physician scientist and biopharmaceutical executive wit

    2/4/26 8:30:00 AM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    WEST ELM LAUNCHES NEW COLLABORATION WITH PINK CHICKEN

    The Collection Brings Pink Chicken's Popular Prints to Modern Home Furnishings Global design company, West Elm, a portfolio brand of Williams-Sonoma, Inc. (NYSE:WSM), the world's largest digital-first, design-led and sustainable home retailer, today announced the launch of a new collaboration with Pink Chicken, the beloved children's clothing brand known for its joyful prints and timeless charm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260202172138/en/Pink Chicken for West Elm Kids (Photo: West Elm) Pink Chicken for West Elm Kids reimagines Pink Chicken's signature prints for kids' spaces. Designed for the spring season

    2/2/26 9:00:00 AM ET
    $WSM
    Home Furnishings
    Consumer Discretionary

    DXC Names Rob Le Busque as Asia Pacific & Japan Leader

    ASHBURN, Va., Feb. 1, 2026 /PRNewswire/ - DXC Technology (NYSE:DXC), a leading enterprise technology and innovation partner, today announced the appointment of Rob Le Busque as President of Asia Pacific & Japan (APJ), effective immediately. Le Busque will report to T.R. Newcomb, Chief Revenue Officer. In his new role, Le Busque will be responsible for shaping DXC's APJ growth strategy, strengthening executive client relationships, and driving go-to-market execution and sales excellence across the region. He will align teams around priority industries and strategic accounts whi

    2/1/26 2:00:00 PM ET
    $DXC
    EDP Services
    Technology

    $AFRM
    $AKA
    $AMRS
    $APCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $AFRM
    $AKA
    $AMRS
    $APCX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care